Literature DB >> 2078996

Antihypertensive medications and depression.

M H Beers1, L J Passman.   

Abstract

The association between antihypertensive medications and depression has been recognised for over 40 years. More recently, our understanding of the role of neurotransmitters in the aetiology of depression has helped us understand how antihypertensive drugs cause depression. Biogenic amine depletion is now believed to underlie the organic nature of depression, and many of the drugs used to treat hypertension interfere with this system. There is now compelling evidence that both reserpine and alpha-methyldopa can induce or worsen depression through their actions on the central nervous system. beta-Blockers have also been implicated, but the data supporting the link between these drugs and depression are not as certain. Guanethidine, clonidine, hydralazine, and prazosin appear to pose little risk in causing depression, although rare occurrences have been reported. Diuretics, calcium channel blockers, and angiotensin converting enzyme (ACE) inhibitors appear to have the lowest association with depression and are therefore the drugs of choice when depression is a risk. Physicians should know which drugs introduce the risk of causing or worsening depression. The wide array of medications now available to treat hypertension offers alternatives that pose low risk. All patients receiving medication to treat hypertension should be evaluated periodically for depression, and if depression occurs, medication should be suspected as playing a role in its aetiology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078996     DOI: 10.2165/00003495-199040060-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  46 in total

1.  Psychiatric aspects of hypertension.

Authors:  D Wheatley; M Balter; J Levine; R Lipman; M L Bauer; R Bonato
Journal:  Br J Psychiatry       Date:  1975-10       Impact factor: 9.319

Review 2.  The central nervous system and effective antihypertensive effects of a calcium channel blocker.

Authors:  H Takahashi; M Yoshimura
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

3.  Brain biogenic amine depletion and mood.

Authors:  J Mendels; A Frazer
Journal:  Arch Gen Psychiatry       Date:  1974-04

Review 4.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

5.  Increased antidepressant use in patients prescribed beta-blockers.

Authors:  J Avorn; D E Everitt; S Weiss
Journal:  JAMA       Date:  1986-01-17       Impact factor: 56.272

6.  The hypertensive psychiatric patient: pharmacologic problems.

Authors:  M G Sandifer
Journal:  J Clin Psychiatry       Date:  1978-09       Impact factor: 4.384

Review 7.  Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.

Authors:  W S Colucci
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

8.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

9.  Psychotropic effects of enalapril maleate in normal volunteers.

Authors:  D Olajide; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 10.  Drug-induced mood disorders.

Authors:  J Ananth; A M Ghadirian
Journal:  Int Pharmacopsychiatry       Date:  1980
View more
  11 in total

1.  Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.

Authors:  H T Sørensen; L Mellemkjaer; J H Olsen
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

2.  Interaction of drugs amlodipine and paroxetine with the metabolizing enzyme CYP2B4: a molecular dynamics simulation study.

Authors:  Abbas Yousefpour; Hamid Modarress; Fatemeh Goharpey; Sepideh Amjad-Iranagh
Journal:  J Mol Model       Date:  2018-02-23       Impact factor: 1.810

Review 3.  Antihypertensive drugs and cognitive function.

Authors:  Anne-Sophie Rigaud; M G M Olde-Rikkert; Olivier Hanon; Marie-Laure Seux; Françoise Forette
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

4.  Pharmaceutical Side Effects and Mental Health Paradoxes among Racial-Ethnic Minorities.

Authors:  Jason Schnittker; Duy Do
Journal:  J Health Soc Behav       Date:  2020-02-01

Review 5.  Can drugs cause depression? A review of the evidence.

Authors:  S B Patten; E J Love
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

Review 6.  Drug-induced depression in the aged. What can be done?

Authors:  L Ganzini; J R Walsh; S B Millar
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

Review 7.  Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation.

Authors:  Jerusha B Detweiler-Bedell; Michael A Friedman; Howard Leventhal; Ivan W Miller; Elaine A Leventhal
Journal:  Clin Psychol Rev       Date:  2008-09-09

Review 8.  Drug-induced depression. Incidence, avoidance and management.

Authors:  S B Patten; E J Love
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 9.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

10.  Hypertension Treatment Modality and Suicide Risk Among Veterans in Veterans Health Administration Care From 2015 to 2017.

Authors:  Kallisse R Dent; Cameron A Griffin; John F McCarthy; Ira R Katz
Journal:  JAMA Netw Open       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.